Latest Headlines

Latest Headlines

'Fossil' virus discovery could lead to HIV immunotherapy

A new discovery of an ancestral fossil virus buried within everyone's genomes might provide the key to eradicating HIV.

Genetic variant may protect against Alzheimer's

Drug development in the Alzheimer's field has been riddled with failures, and many research efforts have focused on pinpointing genetic and environmental factors responsible for causing or accelerating the progression of the disease.

Compound prevents blindness, diabetes in rodents

A chemical compound designed by researchers at the University of California, San Francisco, protected mice and rats against degenerative forms of blindness and diabetes by targeting a central stress response area.

Blocking cell migration could stop cancer spread

Researchers have discovered that, when triggered, certain chemical signals can cause cells to transform into an invasive, liquidy state, giving them the ability to navigate freely through the body. The findings could help drug developers produce new techniques to halt the spread of cancer cells and prevent secondary tumors.

Schizophrenia-linked genetic variation causes abnormal brain cell development

In an effort to more deeply understand the risk factors of schizophrenia, Johns Hopkins researchers have found how a genetic abnormality associated with the mental disorder alters brain cell development.

Emory scientists ID potential PTSD drug

An experimental drug that appears to make memories of upsetting events less permanent in mice may help speed the development of treatments for post-traumatic stress disorder.

Enzyme inhibitor could curb post-stroke injury

A drug that blocks the enzyme Cdk5 has the potential to reduce stroke injury, according to researchers at the University of Texas Southwestern Medical Center.

New antibiotic may combat drug-resistant tuberculosis

As cases of drug-resistant tuberculosis rise worldwide, doctors have fewer effective options with which to treat patients. But scientists have successfully modified the precursor to one of the common antibacterial drugs used to treat tuberculosis, an important step toward developing new therapies that can treat this growing global health concern.

Alzheimer's compound targets abnormal blood clots in brain

A compound developed by researchers at Rockefeller University may be able to slow the progression of Alzheimer's by interfering with how the plaque-forming amyloid-β protein contributes to the formation of blood clots.

Experimental heart disease vaccine lowers arterial plaque in mice

Researchers at La Jolla Institute for Allergy and Immunology in California are spearheading an effort to develop the first vaccine for heart disease.